ft 20 jul 94 uk compani news fresh trial cantab renal drug cantab pharmaceut biotechnolog compani begun new round trial kidney transplant drug write daniel green trial first placebo control phase ii design assess well drug work go well would put much larger phase iii trial approv product launch 1997 drug develop baxter intern us healthcar compani drug code name lm cd45 design reduc chanc newli transplant kidney reject patient lm cd45 hold promis reduc frequenc acut reject therebi improv success rate cost effect transplant procedur said mr joseph presid baxter renal divis mr paul haycock chief execut said compani investig use drug prevent reject transplant organ